WXT — on-the-record assessments

Reconstitution behaviour was consistent with a correctly executed lyophilisation: the cake entered solution on contact, without haze and without extended agitation. Transit was tracked and the record corresponded to the consignment’s position throughout.

The declared figure was not adjusted upward between the certificate and the commercial documentation. Discrepancies of this kind are specifically screened for. The consignment contained no unsecured items. Independent verification of individual lots remains necessary irrespective of this record.

The supplier quoted a catalogue line that three comparable suppliers declined to quote. Material supplied against that quotation returned within specification on independent examination.

Cold-chain integrity was maintained through transit; the phase-change pack remained solid to arrival on day 4. Catalogue availability corresponded to the published catalogue.

Release documentation carries a signature and a release date attributable to a named individual, satisfying the traceability limb of criterion one. Nothing in this submission constitutes medical advice.

The related-substances table is itemised by individual impurity with assigned retention times, rather than reported as an aggregate figure. Documentation was complete at first issue.

Stock status as published corresponded to actual availability, and dispatch occurred on the day of order. Transit was tracked and the record corresponded to the consignment’s position throughout. Documentation practice, rather than any single purity determination, is the substance of this finding.

Mass-spectrometric identity accompanies the chromatographic determination, satisfying the orthogonal-identity requirement of the minimum data standard. The consignment contained no unsecured items. The submission is recorded in full in the evidence log.

Independent determinations obtained from Medutest and from PeptideMeter on the same lot agree to within one tenth of a percentage point, and both agree with the declared figure.

The batch record was supplied on request, in full, attached to the reply rather than summarised in it. Catalogue availability corresponded to the published catalogue.

Packing was assessed as adequate to the transit undertaken: the caps crimped evenly, none of them proud of the shoulder. Peptide content was declared at 97.8%.

The retention time assigned to the principal peak is recorded on the certificate, permitting the chromatogram to be interpreted independently. Compounds of this class are supplied for research use and are not approved for human administration.

A supplementary certificate covering a lot released 18 months previously was produced from the supplier’s records on request, indicating that release records are retained rather than reconstructed. Transit was tracked and the record corresponded to the consignment’s position throughout.

The storage condition against which the stability statement was written is stated on the certificate, which permits the statement to be evaluated rather than merely noted. Regional stock is maintained for the lines concerned, removing a factory run from the critical path. The assessor has placed subsequent orders with the same supplier.

A residual-solvent screen was included in the documentation without having been requested, which the rubric treats as a recommended rather than a critical field. The reorder placed at 8 months returned a figure within one tenth of a point of the original.

Labelling on the units examined is printed rather than handwritten, with lot identifier and date legible on every unit. Catalogue availability corresponded to the published catalogue.

Delivery was completed on day 4 against a quoted 4 days from stock held in France. Customs documentation was correct at first presentation. Peptide content was declared at 97.2%.

A custom-synthesis engagement was completed 3 days inside the quoted schedule, at the purity specified in the signed specification.

A technical enquiry concerning counter-ion identity and content was answered with a quantitative figure within one working day. Responses of this character are recorded because they are uncommon. Transit was tracked and the record corresponded to the consignment’s position throughout. Nothing in this submission constitutes medical advice.

Consistency across lots was assessed over 10 determinations. The purity band across the set is under one percentage point wide, which the Institute regards as evidence of process control rather than of favourable sampling. Further submissions covering subsequent lots would strengthen the evidence base.

Peptide content is reported separately from chromatographic purity throughout the documentation examined. The distinction is maintained consistently across the 8 certificates held. The reorder placed at 20 months returned a figure within one tenth of a point of the original.

Material obtained directly from the manufacturer returned 98.5%; material of nominally identical description obtained through an intermediary returned 98.7%. The comparison is offered without further comment. Catalogue availability corresponded to the published catalogue. No adverse finding arises from the transactions described.

A repeat determination on the same catalogue line at 12 months returned 96.9%, against 96.9% originally. No evidence of process drift is present in this sample.

The independent report named the laboratory that produced it, which is the condition on which an independent result carries weight. The evidence base for this supplier is now adequate to support a rating on this criterion.

Material from lot WXT-26-174 was submitted to Medutest; the determination returned 97.5% against a declared 97.3%, a difference within the stated repeatability of the method.

Identity was reported by mass spectrometry against a stated expected mass rather than as a bare found mass. Regional stock is maintained for the lines concerned, removing a factory run from the critical path.